Literature DB >> 3428672

An epidemic of pseudomembranous colitis: importance of person to person spread.

N P Nolan1, C P Kelly, J F Humphreys, C Cooney, R O'Connor, T N Walsh, D G Weir, D S O'Briain.   

Abstract

Twenty three cases of pseudomembranous colitis (PMC) occurred in three hospitals in 10 months. Retrospective analysis shows that they represented a single epidemic with a readily traceable chain of person-to-person contact within and between hospitals. Most patients had severe pre-existing illness and all had broad spectrum antibiotics, including either ampicillin/amoxycillin, a broad spectrum cephalosporin (particularly cefotaxime), or both. All patients had severe diarrhoea and all responded to vancomycin, but relapse occurred in five. Ten patients eventually died, principally because of underlying disease rather than from PMC. Failure to find fibrin thrombi in blood vessels in biopsies and the scanty distribution of non-invasive bacteria supports the concept of mucosal damage by bacterial toxin, rather than by direct infection, or ischaemia. Although environmental colonisation cannot be excluded, the observed pattern of spread suggests a major role for direct person-to-person crossinfection in the spread of disease in this outbreak.

Entities:  

Mesh:

Year:  1987        PMID: 3428672      PMCID: PMC1433700          DOI: 10.1136/gut.28.11.1467

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

Review 2.  Antimicrobial agent-induced diarrhea--a bacterial disease.

Authors:  W L George; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  The carrier state: Clostridium difficile.

Authors:  R H George
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

4.  Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination.

Authors:  F J Tedesco
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

5.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

6.  Oral vancomycin for antibiotic-associated pseudomembranous colitis.

Authors:  F Tedesco; R Markham; M Gurwith; D Christie; J G Bartlett
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

7.  Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases.

Authors:  D W Milligan; J K Kelly
Journal:  J Clin Pathol       Date:  1979-12       Impact factor: 3.411

8.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

9.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

10.  Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis.

Authors:  M E Mulligan; W L George; R D Rolfe; S M Finegold
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

View more
  7 in total

1.  Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital.

Authors:  S K Nath; S Salama; D Persaud; J H Thornley; I Smith; G Foster; C Rotstein
Journal:  Can J Infect Dis       Date:  1994-11

Review 2.  Dentists, antibiotics and Clostridium difficile-associated disease.

Authors:  N Beacher; M P Sweeney; J Bagg
Journal:  Br Dent J       Date:  2015-09-25       Impact factor: 1.626

3.  Oral rehydration therapy: a Third World solution applied to intensive care.

Authors:  H G Gallagher; D M Phelan
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

4.  Clostridium difficile infection as a cause of severe sepsis.

Authors:  S E Lowenkron; J Waxner; P Khullar; J S Ilowite; M S Niederman; A M Fein
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

5.  The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients.

Authors:  K C Kent; M S Rubin; L Wroblewski; P A Hanff; W Silen
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

6.  Co-morbidity, not age predicts adverse outcome in clostridium difficile colitis.

Authors:  TS Dharmarajan; M Sipalay; R Shyamsundar; EP Norkus; CS Pitchumoni
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

7.  Case-control analysis of clostridium difficile-associated diarrhea on a gynecologic oncology service.

Authors:  S E Waggoner; J Barter; G Delgado; W Barnes
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.